Rosa Rosello
Huesca, AR, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study.
Journal: RMD open
Published: December 15, 2022
Tuberculosis infection in an unusual location
Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Published: April 11, 2020
Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER.
Journal: Arthritis research & therapy
Published: March 16, 2018
Objectives and methodology of BIOBADASER phase iii.
Journal: Reumatologia clinica
Published: May 03, 2017
A composite indicator to assess the quality of care in the management of patients with rheumatoid arthritis in outpatient rheumatology clinics.
Journal: Reumatologia clinica
Published: December 20, 2016
VARIAR Study: Assessment of short-term efficacy and safety of rituximab compared to an tumor necrosis factor alpha antagonists as second-line drug therapy in patients with rheumatoid arthritis refractory to a first tumor necrosis factor alpha antagonist.
Journal: Reumatologia clinica
Published: July 06, 2015
PASH syndrome associated with osteopoikilosis.
Journal: International journal of dermatology
Published: April 23, 2014
Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 08, 2013
Comparative effectiveness of switching to alternative tumour necrosis factor (TNF) antagonists versus switching to rituximab in patients with rheumatoid arthritis who failed previous TNF antagonists: the MIRAR Study.
Journal: Annals of the rheumatic diseases
Published: June 28, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026